Source link : https://newshealth.biz/health-news/which-second-line-therapy-is-better-for-right-sided-crc/
TOPLINE: Continuing anti-vascular endothelial growth factor (VEGF) therapy plus chemotherapy in the second-line setting led to a small but nonsignificant increase in overall survival in patients with right-sided, RAS/RAF wild-type metastatic colorectal cancer (CRC) compared to patients who received anti-epidermal growth factor receptor (EGFR) therapy plus chemotherapy. METHODOLOGY: Despite limited evidence, guidelines recommend anti-EGFR therapy […]
The post Which Second-Line Therapy Is Better for Right-Sided CRC? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-23 12:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8